Rivaroxaban for treatment in venous thrombosis in children

Update Il y a 4 ans
Reference: EUCTR2014-000565-47

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary efficacy objective is: To assess the incidence of symptomatic recurrent venous thromboembolism The principal safety objective is:  To assess the incidence of overt major and clinically relevant non-major bleeding.


Inclusion criteria

  • Venous Thrombosis